World Health Organization (WHO) (T-score of <−2.5 at the femoral neck, calculated using the young white female normal reference database) and the National Osteoporosis Foundation (NOF) criteria (T-score of <−2.5 at the femoral neck, total hip or lumbar spine, calculated using the young white male normal reference database). The prevalence of osteoporosis using the WHO criterion was 1.1% and using the NOF criterion was 13%, while that of vertebral fractures was 21.3%. The area under the curve (AUC) for the relationship between BMD and vertebral fracture prevalence was 0.64. The odds ratio for osteoporosis using the WHO definition was 2.57 (p = 0.13), and 1.78 (p = 0.007) using the NOF definition. Vertebral fracture prevalence rose with age. The prevalence of osteoporosis increased only moderately in men aged >70 years with the WHO criterion, and showed no change using the NOF definition. The prevalence of osteoporosis in Spanish men using the WHO definition is too small to have any meaningful clinical use. Although the figure is higher using the NOF definition, it would seem that population-based studies of BMD in men are of questionable value.
Introduction
Osteoporosis is a major public health problem that not only affects postmenopausal and elderly women but also affects men [1] . Approximately 25-30% of osteoporotic fractures occur in males and their morbidity and mortality rates, at least after hip fracture, are higher in men than in women [2] . Nevertheless, male osteoporosis has been much less studied than postmenopausal osteoporosis, and Abstract The aim of this study was to assess the prevalence of densitometric osteoporosis and vertebral fractures in Spanish men aged ≥50 years, and to study how the relationship between them may change depending on how osteoporosis is diagnosed. A community-based population of 1003 men aged ≥50 years was studied. Bone mineral density (BMD) was measured by DXA at the lumbar spine, femoral neck and total hip. Vertebral fractures were assessed by lateral thoracic and lumbar spine radiographs. The prevalence of osteoporosis was estimated with both the Electronic supplementary material The online version of this article (doi:10.1007/s00774-017-0812-0) contains supplementary material, which is available to authorized users.
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its epidemiology is less well known [1, 3] . Notably, studies on the prevalence of male densitometric osteoporosis have often led to conflicting results [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The discrepancies are attributable, at least in part, to the fact that different criteria have been proposed for its diagnosis. Hence the diagnosis of osteoporosis in men as defined by the World Health Organization (WHO) is based on the cut-off value of femoral neck bone mineral density (BMD) used in women (T-score of −2.5 at the femoral neck, calculated using the young white female normal reference database) [16] . However, the diagnosis of osteoporosis in men used by the National Osteoporosis Foundation (NOF) is defined as a T-score of ≤−2.5 at the femoral neck, total hip or lumbar spine, calculated from the young white male normal reference database [17] . A study by Ensrud et al. may be cited as an example of the difference by using one rather than another definition [14] . In their study, 2.2% or 9.4% of men aged ≥65 years were identified as having osteoporosis according to the WHO or NOF definition, respectively.
Furthermore, discrepancies regarding epidemiological data on male osteoporosis may be related to factors other than osteoporosis definition, such as secular changes, the country where the study is carried out, the age of the population assessed and, ultimately, technical and methodological reasons. Looker et al. [6] , using the WHO definition, reported a 2% osteoporosis prevalence in men aged ≥50 years in the National Health and Nutrition Examination Survey (NHANES) carried out during 2005-2006, whereas the figure was 4% in those from the NHANES III study, which was conducted during 1988-1994 [5] . In 2000, the prevalence of osteoporosis reported in Sweden in men aged 50-84 years using the WHO definition was 6.3% [18] . This study shows a prevalence of 7.8% in men aged 70-79 years, and of 16.6% in men aged 80-84 years.
Some controversy also exists regarding vertebral fracture prevalence in men. Again, discrepancies may be attributed to the different criteria used to identify a vertebral fracture. For instance, the European Vertebral Osteoporosis Study [19] showed that age-standardized vertebral fracture prevalence across Europe was 12.2% when assessed by the McCloskey et al. [20] method, and 20.2% when estimated with the method of Eastell et al. [21] . These discrepancies may decrease if a specific definition of vertebral fracture becomes the standard approach, as seems to be the case with the method of Genant et al. [22] , which is being widely accepted at the present time. However, because of the subjective nature of the X-ray reading the results can vary from one study to another. In addition to this, other factors such as the age and the place of the population studied, may justify some of the differences reported on the prevalence of vertebral fractures.
Since the male prevalence of both densitometric osteoporosis and vertebral fractures differs with their definition and other above-mentioned factors, such as the place and maybe even the timing of the study, we think it would be of interest to report our experience on this issue, with the aim of providing new information on the subject. This may be of particular relevance given the scarcity of information that exists on this topic in Mediterranean countries, and more specifically in Spain.
Materials and methods

Study design and participants
The study population consists of the men enrolled in the Camargo Cohort Study. Full details of this cohort have been previously reported [23, 24] . Briefly, this cohort was set up with postmenopausal women and men aged ≥50 years attending a Primary Care Center in Northern Spain (Camargo, Cantabria) for medical reasons or for their regular programmed health check, whichever happened first. Potential participants who did not come to their Primary Care Center for any of the above reasons during the recruitment period were telephoned and invited to participate. All participants were white, as are >95% of people in our region (Cantabria). Exclusion criteria were either having the principal residence outside the region or having experienced a trauma which could call into question the fragility nature of the fractures. Being unable to attend the recruiting Primary Care Center or to undergo the planned tests were other exclusion criteria. The study was approved by the local Ethics Committee (Comité Ético de Investigación Clínica de Cantabria-IDIVAL. Internal Code 2014.155), and all subjects gave written informed consent.
At the baseline visit, men were interviewed and all participants provided data regarding risk factors for osteoporosis and fractures following a structured questionnaire (Supplemental data, Appendix A).
Laboratory measurements
Blood samples were obtained from an antecubital vein in the morning. Routine biochemical parameters were measured by standard automated methods in an ADVIA 2400 Chemistry System autoanalyser (Siemens Healthcare Diagnosis, Eschborn, Germany).
BMD assessment and osteoporosis definition
BMD was measured by DXA (Hologic QDR 4500, Bedford, MA, USA) at the lumbar spine (L2-L4), femoral neck, and total hip. In vivo precision was 0.4-1.5% at the different measurement sites. Results were expressed as g/cm 2 and T-score. The prevalence of osteoporosis was estimated in two ways. First, as a T-score of ≤ −2.5 at the femoral neck calculated using the young white female normal reference database (WHO definition). Second, as a T-score of ≤ −2.5 at the femoral neck, total hip or lumbar spine, calculated using the young white male normal reference database (referred to as NOF definition). Lumbar spine reference values were obtained from the study conducted in a Spanish population by Díaz-Curiel et al. [9] (1.039 ± 0.120 mg/cm 2 for men). Those for the hip were taken from the NHANES III reference database [5] . Quality control was performed according to the usual standards [25] .
Vertebral fracture assessment
Thoracic and lumbar X-rays were taken, centered at the T7 and L3 vertebrae, respectively. Vertebral fractures were identified according to the method of Genant et al. [22] . Radiographs were reviewed independently by two of the authors who were blinded to any other clinical data. Disagreements were resolved by consensus. Hereafter we refer to grade 1 fractures (loss of vertebral height between 20 and 25%) as 'mild', grade 2 (loss between 25 and 40%) as 'moderate', and grade 3 (loss >40%) as 'severe'.
Statistical analysis
Results were expressed as mean ± SD or percentages, as appropriate. The prevalence of both vertebral fractures and densitometric osteoporosis was adjusted by age to the whole Camargo population of men aged ≥50 years, according to the 2011 population registry of the area. Multivariate logistic regression was performed to assess the independent effect of osteoporosis (defined either with the WHO or with the NOF criteria) on the prevalence of vertebral fractures, estimating the corresponding odds ratios (OR). The area under the ROC curves (AUC) plotting the BMD femoral neck against the vertebral fractures prevalence was also calculated.
Results
A total of 1003 out of 1110 identified eligible men (90.4%) were recruited (Supplemental data, Fig. 1 ). Their baseline characteristics are shown in Table 1 . As can be seen, only 20 patients (2% of men) were receiving treatment for osteoporosis (17 bisphosphonates, 2 calcitonin and 1 strontium ranelate).
Osteoporosis prevalence
When diagnosed using the WHO definition, the prevalence of osteoporosis was 1.1% (95% CI 0.4-1.8). With the NOF definition, this prevalence was 13.0% (95% CI 10.8-15.0) ( Table 2 ). There were marked differences between the proportion of participants with BMD ≤ −2.5 SD (male T-score) at the spine (11.7%; 95% CI 9.6-13.7), at the femoral neck (2.4%; 95% CI 1.4-3.4) and at the total hip (0.6%; 95% CI 0.1-1.1). Therefore, with the gender-specific T-score, the prevalence of osteoporosis in our study population was approximately five times higher at the spine than at the femoral neck. The percentage of men with a T-score of ≤ −2.5 at the femoral neck was more than twice as high when the T-score was calculated with the male reference than with the female (2.4 and 1.1%, respectively).
Vertebral fracture prevalence
The overall prevalence of radiographic vertebral fractures was 21.3% (95% CI 18.7-23.9), and that of moderate and severe fractures together was 6.7% (95% CI 5.1-8.3) [5.1% (95% CI 3.7-6.5) for moderate and 1.6% (95% CI 0.8-2.4) for severe fractures].
Changes over time
The prevalence of all vertebral fractures increased with age from 12.9% (95% CI 6.4-19.5) in men aged 50−54 years to 32.6% (95% CI 25.4-39.8) in men aged >74 years. Moderate and severe fracture prevalence also increased from 1.8% (95% CI 0.2-6.1) to 10.7% (95% CI 5.9-15.5) ( Table 3 ; Fig. 1 ). These figures are in sharp contrast with the absence or virtually absent increase in densitometric osteoporosis with aging. No change was observed until late in life (>70 years using the WHO definition and >75 years using the NOF definition) ( Table 2 ). Such modest changes reflect the small modification in BMD with age. A slight decrease of femoral neck BMD was noted in men aged ≥75 years (p < 0.01). Curiously, at the lumbar spine, a small non-significant age-related gain was observed (Fig. 2) , which could probably be interpreted as due to osteoarthritis development with age.
Univariable and multivariable analysis
The mean value of BMD at the femoral neck in men with vertebral fracture was 0.793 (±0.129) g/cm 2 , and 0.825 (±0.120) g/cm 2 (p < 0.001) in men without, resulting in a difference of 3.8%, which represents 0.27 SD. The corresponding figures at the spine were 0.963 (±0.154) and 1.035 (±0.155) g/cm 2 (p < 0.001), respectively, resulting in a difference of 7%, which represents 0.46 SD. At the total hip, the corresponding figures were 0.942 (±142 g/cm 2 ) and 0.986 (±0.121 g/cm 2 ) (p < 0.001), resulting in a difference of 4.5%, which represents 0.34 SD.
In the multivariable analysis, after controlling for potential confounding factors (age, weight, height, BMI, education level, exercise, family history of hip fracture, smoking and alcohol intake, dairy calcium intake, number of falls in the previous year, causes of secondary osteoporosis and chronic diseases), it was found that when defining osteoporosis with the NOF criterion, the presence of osteoporosis, along with age and history of previous fracture, remained independently associated with prevalent vertebral fractures (OR 1.78 (95% CI 1.17-2.72; p = 0.007). However, when the same analysis was performed defining osteoporosis with the WHO criterion, the corresponding OR for osteoporosis was non-significant (2.57 (95% CI 0.75-8.85; p = 0.13).
Area under the ROC curves
The AUC for the relationship between femoral neck BMD and vertebral fracture prevalence was 0.64. In order to determine whether using the −2.5 female T-score as a cut-off value behaves better than the −2.5 male T-score, the operating characteristics of each of them were studied ( Table 4) . As can be seen, there were practically no differences between the sensitivity, specificity, positive and negative predictive values, or positive and negative likelihood ratios, determined with both criteria
Discussion
The prevalence of male osteoporosis in our study population, as defined by the WHO criterion [16] , was only 1.1%; however, it rose to 13% when using the NOF criterion [17] . The prevalence of all vertebral fractures as a whole was 21.3%, and that of moderate or severe fractures considered together was 6.7%. Vertebral fracture prevalence increased with age, while densitometric osteoporosis prevalence remained unchanged until late in life (>70-75 years).
Worldwide studies on the prevalence of densitometric osteoporosis in men have led to conflicting results. The main reason is the double debate about whether BMD must be measured only at the femoral neck, or also at the spine and the total hip, and about whether a male or female reference must be used. The WHO supports the measurement of BMD at the femoral neck and the use of the cut-off value established for women (T-score of −2.5 calculated with the young white female normal reference database) [16] . However, the NOF advocates measurement at the three sites, with a T-score threshold of −2.5, calculated with the young white male normal reference database [17] . The use of one or the other definition may imply big differences in the prevalence of osteoporosis. For instance, Ensrud et al. [14] reported a prevalence of 2.2% in men aged ≥65 years using the WHO definition, and a prevalence of 9.4% using the NOF definition. In our own study, carried out in men aged ≥50 years, the corresponding figures were 1.1% and 13%, respectively. Looker et al. reported a 2% osteoporosis prevalence in men aged ≥50 years in the NHANES study carried out during 2005-2006 using the WHO definition [6] . Curiously, the figure had been 4% in the previous NHANES III study (1988) (1989) (1990) (1991) (1992) (1993) (1994) [5] . In a Swedish study published in 2000, the prevalence of osteoporosis, defined in the same way, in men aged 50-84 years was 6.3% [18] . Therefore, not only is the prevalence of osteoporosis higher when using the NOF instead of the WHO definition, but other factors such as the year and the place of the study may also contribute to the variability [26, 27] . Indeed, we have seen in the figures above that the prevalence, defined with the same WHO criterion, ranges from 1.1% in our own study to 6.3% in the study from Sweden, with intermediate values in the NHANES studies. Of note, our results suggest that Spanish prevalence of osteoporosis at the femoral neck is lower than that of men from either the United States or from Sweden. Such findings were not surprising, since hip fracture incidence is also lower in Spain than in either of these countries. According to information published by the WHO [28] and by the International Osteoporosis Foundation [29] , Swedish people suffer approximately 2.5-3.0 times more hip fractures than Spanish people, and people from the US suffer approximately 1.2-1.4 times more; these ratios apply to both men and women.
Osteoporosis may be diagnosed either on a clinical (the presence of a fragility fracture) or densitometric basis. If diagnosed on a clinical basis, at least 21% of the men in our study have osteoporosis. This is in sharp contrast with the This difference must be attributed to the fact that, contrary to what happens with BMD at the femoral neck, the NOF definition includes BMD at the spine, and there is a better relationship between spine BMD and vertebral fractures than between these fractures and femoral neck BMD. In this regard, it is worth taking into account that the rationale under the WHO definition is the claim that the relationship between areal BMD and fracture risk is the same in men as in women when adjusted by age [30] , a statement that may be correct when BMD is measured at the femoral neck and the location of the fractures considered is the hip. However, this may not hold true for the relationship between femoral neck BMD and vertebral fractures [31] . To establish the risk of vertebral fracture, a procedure that includes spine BMD is preferable, as is the case with the NOF definition.
As previously stated, the AUC was 0.64. For the sake of comparison, we also assessed the AUC in women of the same cohort (the Camargo Cohort), and found a clearly higher figure of 0.77. This result highlights another interesting concept, i.e., that the association between BMD and vertebral fractures is stronger in women than in men. One factor that may help explain this difference is the fact that men experience more trauma through their lives, related to a higher degree of physical activity than women. In women, however, fractures seem to keep a closer relationship with the decrease in bone mass than with suffering from trauma. In the later stages of life, however, there is an increase in the tendency to fall in both men and women, so by this time the traumatic component is common to both sexes.
The prevalence of vertebral fractures reported by different studies has been similar to what has been reported above for densitometric osteoporosis, i.e., quite variable [20, 21, 32, 33] . Again, the main reason is that several methods have been in use. Other factors, such as the type of population and the place of study, may also play a role. An important fact to remember is that the assessment of a vertebral fracture has an element of subjectivity that is not present in BMD measurement, since DXA provides a very objective result, hardly susceptible to influence by personal biases. For these reasons, comparing our results on vertebral fracture prevalence with those from other studies is a task that entails uncertainty and questionable conclusions. Another Spanish study [32] also carried out with the Genant method, reported a prevalence of 20.8% (95% CI 13.4-29.9%), which is close to our result. However, a recent publication by Ensrud et al. [33] performed in the United States using the Genant method estimated a prevalence of only 11.1%. In an accompanying editorial, Briot et al. [34] comment on the fact that the authors evaluate the presence of fractures after a triage performed by trained technicians and that although such a triage is described as reliable, little information is given about it. Clearly, more objective methods of evaluating vertebral fracture prevalence are needed before general statements about its epidemiology may be made. Other definitions of vertebral fracture, such as those by Eastell et al. [21] or McCloskey et al. [20] provide results which, although different, are also in a range (10-25%) well above the percentages of the male osteoporotic population established by the WHO definition [16] . Therefore, variability in the prevalence of vertebral fractures provided by the different methods does not contradict the idea that the WHO definition of male osteoporosis is of little clinical value in establishing the risk of vertebral fractures.
Our study has some limitations. First, the Camargo Cohort is derived from a single geographic region of Spain, and therefore, perhaps our findings cannot be extrapolated to other populations. Second, it is a cross-sectional study. However, the location of the fracture considered (vertebrae) hinders a prospective study. Among the strengths, however, it is worth mentioning that the sample was sufficiently large (>1000 men), the participants were well-characterized, and all BMD measurements were performed with the same device. In addition, the presence of women in the Camargo Cohort allowed us to perform some comparative studies.
To conclude, in Spain the percentage of men classified as osteoporotic according to the WHO definition would be too small to be of much clinical meaning. The figure is far lower than that of osteoporosis defined on clinical grounds by the presence of fractures. In this regard, the NOF definition may be preferable, since by including BMD measurement at both the spine and the hip, it has a greater ability to predict the development of fractures in different locations. In any case, as the relationship between BMD and vertebral fractures is lower in men than in women, BMD is not such a useful tool in men as it is in women. In fact, in men such a study may make sense only for those aged >70-75 years.
